Full-Time
Marketing Manager
Posted on 6/27/2024
Ceribell
201-500 employees
EEG devices for monitoring brain activity
Compensation Overview
$140k - $150kAnnually
Senior, Expert
Remote in USA
- Minimum 5 years in market development roles
- Managed complex market dynamics and multi-faceted initiatives to successful outcomes
- Very skilled in analytic tools (Excel, Altyrx) and Marketing platforms (SFDC, Groove, Adobe, Google Analytics, etc.)
- Highly organized and diligent
- Detail oriented
- Able to manage cross functional projects effectively
- Bachelor’s degree, MBA/MS preferred
- Execute regional programs including KOL development, residency/fellow training, webinars, grand rounds, etc.
- Drive lead quantity, quality, and cultivation for assigned major national trade shows
- Maintain relevant collateral and pitch materials for relevant market segments and stakeholders
- Map and maintain the regional market dynamics to support the sales teams
- Partner with regional sales leaders to deliver business results
Ceribell focuses on developing medical devices that utilize electroencephalogram (EEG) technology to monitor brain activity. Their main product, the Ceribell EEG Headband and Recorder, is designed for use by trained healthcare providers in professional settings. These devices help gather important data about a patient's brain activity, which healthcare professionals can analyze to make informed treatment decisions. Unlike some other EEG devices, Ceribell's products do not provide diagnostic conclusions or automated alerts; instead, they serve as a tool for data collection, particularly in urgent situations like Nonconvulsive Status Epilepticus (NCSE), where timely intervention is crucial. Ceribell differentiates itself by focusing on the speed and efficiency of data gathering, which is vital in critical care scenarios. The company's goal is to enhance the ability of healthcare providers to monitor and respond to neurological conditions effectively.
Company Stage
Series C
Total Funding
$172M
Headquarters
Mountain View, California
Founded
2014
6 month growth
↑ 12%1 year growth
↑ 27%2 year growth
↑ 73%
Simplify's Take
What believers are saying
- Ceribell's recent $102 million equity investment and $50 million financing round indicate strong financial backing for expansion and product development.
- The appointment of experienced leaders like Sean Manni and Joshua Copp positions the company for strategic growth and operational excellence.
- Recognition by Fast Company as one of the World's Most Innovative Companies highlights Ceribell's industry impact and potential for continued innovation.
What critics are saying
- The reliance on healthcare providers to interpret EEG data may limit the device's adoption in settings with less specialized staff.
- The competitive landscape in medical devices and AI-powered diagnostics could pose challenges to Ceribell's market share.
What makes Ceribell unique
- Ceribell's AI-powered point-of-care EEG system is a first-of-its-kind technology, setting it apart from traditional EEG devices.
- The company's focus on rapid, easy-to-use brain monitoring solutions for time-critical conditions like NCSE provides a unique value proposition.
- FDA Breakthrough Device Designation for delirium detection further validates Ceribell's innovative approach in neurodiagnostics.
Help us improve and share your feedback! Did you find this helpful?